Physician profile
Marc A Greenstein
NPI 1154383743
$10,262.82
in general payments reported to CMS, 2019-2025
49 companies · $1,416 in 2025
The $1,416 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,375 · 2020: $848 · 2021: $1,094 · 2022: $1,355 · 2023: $1,570 · 2024: $1,605 · 2025: $1,416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,590.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,761.97 | 2019-2025 | Aquabeam Robotic System |
| Teleflex LLC | $1,260.48 | 2021-2025 | Urolift, Barrigel |
| Medtronic, INC. | $861.82 | 2021-2024 | Interstim |
| Myriad Genetic Laboratories, INC. | $564.89 | 2021-2025 | Prolaris |
| Endo Pharmaceuticals INC. | $479.82 | 2019-2024 | Xiaflex, Aveed |
| Boston Scientific Corporation | $414.10 | 2019-2025 | General - Oncology |
| Sumitomo Pharma America, INC. | $405.91 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $391.61 | 2019-2025 | Xtandi, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $319.09 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $285.70 | 2019-2021 | |
| Myovant Sciences INC. | $265.61 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $236.77 | 2023-2025 | Lynparza |
| Coloplast Corp | $219.63 | 2021-2025 | Titan |
| Accord Healthcare, INC. | $219.30 | 2023-2025 | |
| Pfizer INC. | $183.65 | 2020-2025 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $160.56 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Blue Earth Diagnostics | $158.58 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $154.05 | 2022-2024 | Lynparza, Welireg, Keytruda |
| Ferring Pharmaceuticals INC. | $148.21 | 2019-2025 | Adstiladrin |
| Metuchen Pharmaceuticals | $121.09 | 2020 | |
| Tempus Ai, INC | $117.34 | 2024-2025 | Xt Cdx |
| Endo USA, INC. | $107.96 | 2024-2025 | Xiaflex, Aveed |
| C. R. Bard, INC. & Subsidiaries | $101.56 | 2019-2025 | Bard Urinary Drainage Bag |
| Convatec INC. | $99.63 | 2021-2025 | |
| Verity Pharmaceuticals INC. | $99.20 | 2025 | Trelstar |
| Photocure INC | $97.52 | 2019 | |
| Abbvie INC. | $92.34 | 2019-2023 | |
| Srs Medical Systems, INC. | $85.07 | 2019 | |
| Medtronic USA, INC. | $77.12 | 2019-2020 | |
| Nevro Corp. | $71.27 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $65.09 | 2022 | |
| Laborie Medical Technologies Corp. | $63.53 | 2023-2025 | Optilume Urethral Drug Coated Balloon |
| Sun Pharmaceutical Industries INC. | $62.98 | 2023-2024 | Yonsa |
| Urogen Pharma, INC. | $57.28 | 2024-2025 | |
| Halozyme INC | $55.04 | 2023 | |
| Olympus America INC. | $51.84 | 2019-2025 | Itind System |
| Janssen Biotech, INC. | $50.44 | 2019-2025 | Erleada |
| Tolmar, INC. | $44.71 | 2024 | |
| Axonics, INC. | $41.98 | 2024 | Bulkamid |
| Allergan, INC. | $34.62 | 2019 | |
| Novartis Pharmaceuticals Corporation | $33.90 | 2024 | |
| Innovation Technologies INC | $25.87 | 2025 | Irrisept |
| Pacira Pharmaceuticals Incorporated | $25.53 | 2024 | Iovera, Exparel |
| 180 Medical, INC. | $20.85 | 2021 | |
| Immunitybio, INC. | $17.78 | 2025 | |
| Davol INC. | $14.85 | 2023 | Arista Ah Flexitip |
| Zyla Life Sciences, INC. | $12.13 | 2019 | |
| Travere Therapeutics, INC. | $11.46 | 2020-2021 | |
| Dentsply Ih INC. | $11.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Greenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.